NCT02291289 — SoA extraction uncertainty report

Source: NCT02291289_soa.pdf (Protocol MO29112, Version 9, Appendices 1–5). 26 PDF pages map to document pages 169–194 (PAGEMAP.md). Page 194 (Appendix 6, FOLFOX regimens) is outside the SoA range and was not extracted. The printed footers match PAGEMAP on every page checked. Prompt version 3.8.1. There are 5 tables and 5 JSON files.

Decisions needed (3)

# where call made alternative detail
D1 p170 rows 17, 20 (Table 1); Tables 2/3/5 "(Experimental Arm only)" rows; Tables 2–5 Metastatic tumour tissue / Stool sample rows Explanatory sub-lines printed inside an activity label cell were moved out of activity_name into footnote annotations with synthesised markers n1/n2, bound to that activity. Examples are "Collection of these samples discontinued as of May 2018", the Supplemental Biomarker Program closure sentence and "(Experimental Arm only)". The raw text stays in cell_text. Keep the sub-line as part of the activity name, e.g. "Pulse oximetry (Experimental Arm only)". No synthesised note is then needed. 3.3
D2 p169 row 3 (Table 1); row 2 of Tables 2–5 The per-column timing header row is typed other. It mixes windows ("≤ 28 days"), an anchor ("Day 1 Cycle 1"), recurrence frequencies ("Every 2 cycles…", "Every 3 months…") and a post-dose window. Type the row as visit (one column = one encounter) or as window. 3.2
D3 p174 (Tables 2–5) Appendices 2–5 (maintenance schedules for Cohorts 1–4) are each typed track, with track_label "Cohort 1" … "Cohort 4". Each schedules a mutually exclusive, biomarker-assigned cohort. Appendix 1 (induction for all patients) is main_soa. Type Tables 2–5 as independent main_soa tables. The identical column labels of Cohorts 1 and 4 could also invite a domain reading, but the populations differ. 3.1

Recorded, not open (10)

1. Method

2. Per table

Table Title Type Pages Data cols Activities Rows per page
1 Appendix 1 Schedule of Assessments for All Patients (Screening / Baseline and Induction Treatment Phase) main_soa 169–173 6 (pos 2–7) 21 169: 12, 170: 7, 171: 2, 172: 0, 173: 0
2 Appendix 2 … Maintenance Phase (Cohort 1) track "Cohort 1" 174–178 4 (pos 2–5) 25 174: 14, 175: 10, 176: 1, 177: 0, 178: 0
3 Appendix 3 … (Cohort 2) track "Cohort 2" 179–183 4 24 179: 14, 180: 8, 181: 2, 182: 0, 183: 0
4 Appendix 4 … (Cohort 3) track "Cohort 3" 184–188 4 22 184: 13, 185: 9, 186–188: 0
5 Appendix 5 … (Cohort 4) track "Cohort 4" 189–193 4 26 189: 16, 190: 8, 191: 2, 192: 0, 193: 0

3. Interpretation calls

3.1 Table types (D3)

3.2 Header rows (D2)

3.3 Synthesised markers (D1)

Table Marker Text Bound to
T1 n1 "Collection of these samples discontinued as of May 2018" row 17
T1 n2 Supplemental Biomarker Program closure sentence row 20
T1 pr1 "See Appendix 19" header row 3, col 7
T2 n1 closure sentence rows 21, 23
T2 n2 "Experimental Arm only" rows 9–12
T3 n1 closure sentence rows 20, 22
T3 n2 "Experimental Arm only" rows 15, 16
T3 pr1 "See Appendix 19" header row 2, col 5
T4 n1 closure sentence rows 18, 20
T4 pr1 "See Appendix 19" header row 2, col 5
T5 n1 closure sentence rows 22, 24
T5 n2 "Experimental Arm only" rows 15, 16

4. Merged-mark decisions

5. Annotation text integrity

6. Low-confidence / orphan risk

7. Method provenance (non-default)